MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SKOLNICK, P.
Right arrow Articles by DALY, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SKOLNICK, P.
Right arrow Articles by DALY, J. W.

Molecular Pharmacology, Vol 11, 545-551, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Stimulation of Adenosine 3',5'-Monophosphate Formation by Alpha and Beta Adrenergic Agonists in Rat Cerebral Cortical Slices: Effects of Clonidine

PHIL SKOLNICK 1 and JOHN W. DALY 1

1 National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

Clonidine has no significant effect on basal levels of cyclic 3',5'-AMP in incubated slices of rat cerebral cortex, but this drug and oxymetazoline antagonize norepinerphrine-elicited accumulation of cyclic AMP to a degree which corresponds to the alpha adrenergic component of the norepinephrine response. Phenylephrine has virtually no agonist or antagonist activity in the brain slice system. Clonidine does not antagonize the accumulation of cyclic AMP elicited by maximal concentrations of a beta adrenergic agonist, isoproterenol, and markedly potentiates the stimulatory effects of submaximal concentrations of this agonist. Clonidine completely antagonizes the formation of cyclic AMP elicited by methoxamine, an alpha adrenergic agonist. The results indicate that clonidine and oxymetazoline function as potent antagonists with respect to norepinephrine- and methoxamine-stimulated formation of cyclic AMP in brain tissue, presumably at an alpha adrenergic locus. In addition, clonidine, oxymetazoline, and phenylephrine appear to interact synergistically with the beta adrenergic component of cyclic AMP-generating systems, thus functioning as partial agonists in brain slices under certain conditions.

Note:
ACKNOWLEDGMENT The authors wish to thank Mr. William Padgett and Mrs. Linda Stalvey for excellent technical assistance.

Submitted on October 30, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics